Autoimmunity and Heart Disease
|Causes of Heart Disease|
Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy (NVC) patterns and disease–specific autoantibodies. All SSc–specific auto–antibodies were found, with ACA and anti-Scl-70 being the most prevalent and the association between NVC–pattern and heart/lung involvement was independent of specific anti-ENA antibodies, which might indicate microangiopathy is an important cause of organ involvement. PubMed, Rheumatology (Oxford), 12/10/2016. (Also see Antibodies and Nailfold Videocapillaroscopy)
Idiopathic pulmonary fibrosis (IPF) and coronary artery disease. A more extensive cardiopulmonary exercise test should be performed for better management of IPF patients, not only with the goal of identifying useful prognostic parameters, but also to detect potentially treatable cardiovascular alterations earlier. Multidisciplinary Respiratory Medicine 2014, 9:31. (Also see Pulmonary Fibrosis Correlations)
Prognostic value of N-terminal natriuretic peptides (NT-proANP) in systemic sclerosis (SSc): a single centre study. The high negative predictive value of natriuretic peptides supports the more extensive use in identifying SSc patients with high risk of future cardiac involvement. PubMed, Clin Exp Rheumatol, 2014 Nov-Dec;32 Suppl 6(6):75-81.
Autonomic dysfunction in patients with systemic sclerosis: Correlation with intrarenal arterial stiffness. Autonomic dysfunction (AD) is a feature of SSc, starting early in the disease and possibly preceding the development of fibrosis. International Journal Of Cardiology, 09/04/2014.
United Way of Central New Mexico
United Way of Snohomish County
See ISN News for recent donors, including Pam Hop, Margaret Roof, Winifred Schillberg, Arnold Slotkin, and Juliet Youkhana. Plus donations in honor of Kim Thwaits, and in loving memory of Marta Marx, Jim Miller, and Arlene Marie Petulla.
Click Here to Donate or Shop
or click on the floating green DONATE sclero.org button.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: